Joint effect of insulin signaling genes on insulin secretion and glucose homeostasis

Sabrina Prudente, Eleonora Morini, Lorella Marselli, Roberto Baratta, Massimiliano Copetti, Christine Mendonca, Francesco Andreozzi, Manisha Chandalia, Fabio Pellegrini, Diego Bailetti, Federica Alberico, Hetal Shah, Nicola Abate, Giorgio Sesti, Lucia Frittitta, Piero Marchetti, Alessandro Doria, Vincenzo Trischitta

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Context: Reduced insulin signaling in insulin secreting β-cells causes defective insulin secretion and hyperglycemia in mice. Objective: We investigated whether functional polymorphisms affecting insulin signaling (ie, ENPP1 K121Q, rs1044498; IRS1 G972R, rs1801278; and TRIB3 Q84R, rs2295490) exert a joint effect on insulin secretion and abnormal glucose homeostasis (AGH). Design: Insulin secretion was evaluated by 1) the disposition index (DI) from an oral glucose tolerance test (OGTT) in 829 individuals; 2) insulin secretion stimulation index (SI) in islets from nondiabetic donors after glucose (n = 92) or glibenclamide (n = 89) stimulation. AGH (including impaired fasting glucose and/or impaired glucose tolerance or type 2 diabetes; T2D) was evaluated in case-control studies from the GENetics of Type 2 Diabetes in Italy and the United States (GENIUS T2D) Consortium (n = 6607). Results: Genotype risk score, obtained by totaling individual weighted risk allele effects, was associated with the following: 1) DI (P = .005); 2) glucoseandglibenclamide SI (P = .046 and P = .009); or 3) AGH(odds ratio 1.08, 95% confidence interval 1.03-1.13; P = .001). We observed an inverse relationship between genetic effect and age at AGH onset, as indicated by a linear correlation between AGH-genotype risk score odds ratios and age-at-diagnosis cutoffs (R2 = 0.80, P < .001). Conclusions: Functional polymorphisms affecting insulin signaling exert a joint effect on both in vivo and in vitro insulin secretion as well as on early-onset AGH. Our data provide further evidence that abnormal insulin signaling reduces β-cell function and impairs glucose homeostasis.

Original languageEnglish (US)
JournalJournal of Clinical Endocrinology and Metabolism
Volume98
Issue number6
DOIs
StatePublished - Jun 2013
Externally publishedYes

Fingerprint

Homeostasis
Genes
Insulin
Glucose
Type 2 Diabetes Mellitus
Medical problems
Polymorphism
Odds Ratio
Genotype
Glucose Intolerance
Glyburide
Cell signaling
Insulin-Secreting Cells
Glucose Tolerance Test
Hyperglycemia
Italy
Case-Control Studies
Fasting
Alleles
Confidence Intervals

ASJC Scopus subject areas

  • Biochemistry
  • Clinical Biochemistry
  • Endocrinology
  • Biochemistry, medical
  • Endocrinology, Diabetes and Metabolism

Cite this

Prudente, S., Morini, E., Marselli, L., Baratta, R., Copetti, M., Mendonca, C., ... Trischitta, V. (2013). Joint effect of insulin signaling genes on insulin secretion and glucose homeostasis. Journal of Clinical Endocrinology and Metabolism, 98(6). https://doi.org/10.1210/jc.2012-4282

Joint effect of insulin signaling genes on insulin secretion and glucose homeostasis. / Prudente, Sabrina; Morini, Eleonora; Marselli, Lorella; Baratta, Roberto; Copetti, Massimiliano; Mendonca, Christine; Andreozzi, Francesco; Chandalia, Manisha; Pellegrini, Fabio; Bailetti, Diego; Alberico, Federica; Shah, Hetal; Abate, Nicola; Sesti, Giorgio; Frittitta, Lucia; Marchetti, Piero; Doria, Alessandro; Trischitta, Vincenzo.

In: Journal of Clinical Endocrinology and Metabolism, Vol. 98, No. 6, 06.2013.

Research output: Contribution to journalArticle

Prudente, S, Morini, E, Marselli, L, Baratta, R, Copetti, M, Mendonca, C, Andreozzi, F, Chandalia, M, Pellegrini, F, Bailetti, D, Alberico, F, Shah, H, Abate, N, Sesti, G, Frittitta, L, Marchetti, P, Doria, A & Trischitta, V 2013, 'Joint effect of insulin signaling genes on insulin secretion and glucose homeostasis', Journal of Clinical Endocrinology and Metabolism, vol. 98, no. 6. https://doi.org/10.1210/jc.2012-4282
Prudente, Sabrina ; Morini, Eleonora ; Marselli, Lorella ; Baratta, Roberto ; Copetti, Massimiliano ; Mendonca, Christine ; Andreozzi, Francesco ; Chandalia, Manisha ; Pellegrini, Fabio ; Bailetti, Diego ; Alberico, Federica ; Shah, Hetal ; Abate, Nicola ; Sesti, Giorgio ; Frittitta, Lucia ; Marchetti, Piero ; Doria, Alessandro ; Trischitta, Vincenzo. / Joint effect of insulin signaling genes on insulin secretion and glucose homeostasis. In: Journal of Clinical Endocrinology and Metabolism. 2013 ; Vol. 98, No. 6.
@article{fc46ebd45e7142e0a04a53ac44e7764c,
title = "Joint effect of insulin signaling genes on insulin secretion and glucose homeostasis",
abstract = "Context: Reduced insulin signaling in insulin secreting β-cells causes defective insulin secretion and hyperglycemia in mice. Objective: We investigated whether functional polymorphisms affecting insulin signaling (ie, ENPP1 K121Q, rs1044498; IRS1 G972R, rs1801278; and TRIB3 Q84R, rs2295490) exert a joint effect on insulin secretion and abnormal glucose homeostasis (AGH). Design: Insulin secretion was evaluated by 1) the disposition index (DI) from an oral glucose tolerance test (OGTT) in 829 individuals; 2) insulin secretion stimulation index (SI) in islets from nondiabetic donors after glucose (n = 92) or glibenclamide (n = 89) stimulation. AGH (including impaired fasting glucose and/or impaired glucose tolerance or type 2 diabetes; T2D) was evaluated in case-control studies from the GENetics of Type 2 Diabetes in Italy and the United States (GENIUS T2D) Consortium (n = 6607). Results: Genotype risk score, obtained by totaling individual weighted risk allele effects, was associated with the following: 1) DI (P = .005); 2) glucoseandglibenclamide SI (P = .046 and P = .009); or 3) AGH(odds ratio 1.08, 95{\%} confidence interval 1.03-1.13; P = .001). We observed an inverse relationship between genetic effect and age at AGH onset, as indicated by a linear correlation between AGH-genotype risk score odds ratios and age-at-diagnosis cutoffs (R2 = 0.80, P < .001). Conclusions: Functional polymorphisms affecting insulin signaling exert a joint effect on both in vivo and in vitro insulin secretion as well as on early-onset AGH. Our data provide further evidence that abnormal insulin signaling reduces β-cell function and impairs glucose homeostasis.",
author = "Sabrina Prudente and Eleonora Morini and Lorella Marselli and Roberto Baratta and Massimiliano Copetti and Christine Mendonca and Francesco Andreozzi and Manisha Chandalia and Fabio Pellegrini and Diego Bailetti and Federica Alberico and Hetal Shah and Nicola Abate and Giorgio Sesti and Lucia Frittitta and Piero Marchetti and Alessandro Doria and Vincenzo Trischitta",
year = "2013",
month = "6",
doi = "10.1210/jc.2012-4282",
language = "English (US)",
volume = "98",
journal = "Journal of Clinical Endocrinology and Metabolism",
issn = "0021-972X",
publisher = "The Endocrine Society",
number = "6",

}

TY - JOUR

T1 - Joint effect of insulin signaling genes on insulin secretion and glucose homeostasis

AU - Prudente, Sabrina

AU - Morini, Eleonora

AU - Marselli, Lorella

AU - Baratta, Roberto

AU - Copetti, Massimiliano

AU - Mendonca, Christine

AU - Andreozzi, Francesco

AU - Chandalia, Manisha

AU - Pellegrini, Fabio

AU - Bailetti, Diego

AU - Alberico, Federica

AU - Shah, Hetal

AU - Abate, Nicola

AU - Sesti, Giorgio

AU - Frittitta, Lucia

AU - Marchetti, Piero

AU - Doria, Alessandro

AU - Trischitta, Vincenzo

PY - 2013/6

Y1 - 2013/6

N2 - Context: Reduced insulin signaling in insulin secreting β-cells causes defective insulin secretion and hyperglycemia in mice. Objective: We investigated whether functional polymorphisms affecting insulin signaling (ie, ENPP1 K121Q, rs1044498; IRS1 G972R, rs1801278; and TRIB3 Q84R, rs2295490) exert a joint effect on insulin secretion and abnormal glucose homeostasis (AGH). Design: Insulin secretion was evaluated by 1) the disposition index (DI) from an oral glucose tolerance test (OGTT) in 829 individuals; 2) insulin secretion stimulation index (SI) in islets from nondiabetic donors after glucose (n = 92) or glibenclamide (n = 89) stimulation. AGH (including impaired fasting glucose and/or impaired glucose tolerance or type 2 diabetes; T2D) was evaluated in case-control studies from the GENetics of Type 2 Diabetes in Italy and the United States (GENIUS T2D) Consortium (n = 6607). Results: Genotype risk score, obtained by totaling individual weighted risk allele effects, was associated with the following: 1) DI (P = .005); 2) glucoseandglibenclamide SI (P = .046 and P = .009); or 3) AGH(odds ratio 1.08, 95% confidence interval 1.03-1.13; P = .001). We observed an inverse relationship between genetic effect and age at AGH onset, as indicated by a linear correlation between AGH-genotype risk score odds ratios and age-at-diagnosis cutoffs (R2 = 0.80, P < .001). Conclusions: Functional polymorphisms affecting insulin signaling exert a joint effect on both in vivo and in vitro insulin secretion as well as on early-onset AGH. Our data provide further evidence that abnormal insulin signaling reduces β-cell function and impairs glucose homeostasis.

AB - Context: Reduced insulin signaling in insulin secreting β-cells causes defective insulin secretion and hyperglycemia in mice. Objective: We investigated whether functional polymorphisms affecting insulin signaling (ie, ENPP1 K121Q, rs1044498; IRS1 G972R, rs1801278; and TRIB3 Q84R, rs2295490) exert a joint effect on insulin secretion and abnormal glucose homeostasis (AGH). Design: Insulin secretion was evaluated by 1) the disposition index (DI) from an oral glucose tolerance test (OGTT) in 829 individuals; 2) insulin secretion stimulation index (SI) in islets from nondiabetic donors after glucose (n = 92) or glibenclamide (n = 89) stimulation. AGH (including impaired fasting glucose and/or impaired glucose tolerance or type 2 diabetes; T2D) was evaluated in case-control studies from the GENetics of Type 2 Diabetes in Italy and the United States (GENIUS T2D) Consortium (n = 6607). Results: Genotype risk score, obtained by totaling individual weighted risk allele effects, was associated with the following: 1) DI (P = .005); 2) glucoseandglibenclamide SI (P = .046 and P = .009); or 3) AGH(odds ratio 1.08, 95% confidence interval 1.03-1.13; P = .001). We observed an inverse relationship between genetic effect and age at AGH onset, as indicated by a linear correlation between AGH-genotype risk score odds ratios and age-at-diagnosis cutoffs (R2 = 0.80, P < .001). Conclusions: Functional polymorphisms affecting insulin signaling exert a joint effect on both in vivo and in vitro insulin secretion as well as on early-onset AGH. Our data provide further evidence that abnormal insulin signaling reduces β-cell function and impairs glucose homeostasis.

UR - http://www.scopus.com/inward/record.url?scp=84878505453&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84878505453&partnerID=8YFLogxK

U2 - 10.1210/jc.2012-4282

DO - 10.1210/jc.2012-4282

M3 - Article

VL - 98

JO - Journal of Clinical Endocrinology and Metabolism

JF - Journal of Clinical Endocrinology and Metabolism

SN - 0021-972X

IS - 6

ER -